Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency
Condition(s):Mild Cognitive Impairment; Cerebrovascular InsufficiencyLast Updated:September 28, 2015Completed
Hide Studies Not Open or Pending
Condition(s):Mild Cognitive Impairment; Cerebrovascular InsufficiencyLast Updated:September 28, 2015Completed
Condition(s):Healthy VolunteersLast Updated:June 2, 2016Unknown status
Condition(s):Intrauterine Growth Restriction (IUGR)Last Updated:March 22, 2016Completed
Condition(s):Tardive DyskinesiaLast Updated:November 25, 2009Completed
Condition(s):Sedentary Behavior; Cardiovascular Risk Factor; Mental Stress; Cognitive Change; Cerebrovascular InsufficiencyLast Updated:April 18, 2023Completed
Condition(s):Ischemic Stroke; Revascularization; Blood Pressure; Cerebrovascular Insufficiency; Cerebral Autoregulation; Individuation; Hemorrhagic Transformation Due to Acute StrokeLast Updated:January 5, 2023Not yet recruiting
Condition(s):Respiratory InsufficiencyLast Updated:June 22, 2020Completed
Condition(s):Acute Coronary SyndromeLast Updated:April 3, 2020Completed
Condition(s):Cardioembolic Stroke; Multidisciplinary CommunicationLast Updated:August 12, 2022Active, not recruiting
Condition(s):StrokeLast Updated:April 8, 2021Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.